Age: 7.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Amnesia, Anger, Arthralgia, Dyslexia, Gait inability
Clinical narrative: migraine; severe pain in her knees; crisscross walking/become unable to walk; tremors in her head/hands/legs; panic attacks; OCD intrusive thoughts; severe memory loss including inability to remember friends and eventually even close family; isolated incidents of rages; speech regression; vision abnormalities (inability to see people in color); lost her ability to read/unable to write correctly or remember how to spell for several months; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the parent.  A 7-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 28Nov2021 at 11:00 as dose 2, single (Lot number: FK5127) at the age of 7 years, in left arm for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: IBUPROFEN [IBUPROFEN SODIUM]. Vaccination history included: BNT162b2 (Dose 1, lot number: FK5127, dose administration time: 03:30 PM, vaccine location: Left arm), administration date: 06Nov2021, when the patient was 7-year-old, for COVID-19 Immunization, reaction(s): "severe jaw pain to the point she couldn't open her mouth". The following information was reported: MIGRAINE (hospitalization, disability), outcome "not recovered"; ARTHRALGIA (hospitalization, disability), outcome "not recovered", described as "severe pain in her knees"; GAIT INABILITY (hospitalization, disability), outcome "not recovered", described as "crisscross walking/become unable to walk"; TREMOR (hospitalization, disability), outcome "not recovered", described as "tremors in her head/hands/legs"; PANIC ATTACK (hospitalization, disability), outcome "not recovered", described as "panic attacks"; INTRUSIVE THOUGHTS (hospitalization, disability), outcome "not recovered", described as "OCD intrusive thoughts"; AMNESIA (hospitalization, disability), outcome "not recovered", described as "severe memory loss including inability to remember friends and eventually even close family"; ANGER (hospitalization, disability), outcome "not recovered", described as "isolated incidents of rages"; SPEECH DISORDER (hospitalization, disability), outcome "not recovered", described as "speech regression"; VISUAL IMPAIRMENT (hospitalization, disability), outcome "not recovered", described as "vision abnormalities (inability to see people in color)"; DYSLEXIA (hospitalization, disability), outcome "not recovered", described as "lost her ability to read/unable to write correctly or remember how to spell for several months". The patient was hospitalized for migraine, arthralgia, gait inability, tremor, panic attack, intrusive thoughts, amnesia, anger, speech disorder, visual impairment, dyslexia (hospitalization duration: 4 day(s)). The events "migraine", "severe pain in her knees", "crisscross walking/become unable to walk", "tremors in her head/hands/legs", "panic attacks", "ocd intrusive thoughts", "severe memory loss including inability to remember friends and eventually even close family", "isolated incidents of rages", "speech regression", "vision abnormalities (inability to see people in color)" and "lost her ability to read/unable to write correctly or remember how to spell for several months" required physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (27May2022) Positive, notes: Nasal Swab. Therapeutic measures were taken as a result of migraine, arthralgia, gait inability, tremor, panic attack, intrusive thoughts, amnesia, anger, speech disorder, visual impairment, dyslexia.  Clinical Course: After the first dose, (Name withheld) experienced severe jaw pain to the point she couldn't open her mouth, but this resolved within a week or so. Within days of the second dose, she developed a migraine, severe pain in her knees, she had criss-cross walking and then become unable to walk, she developed tremors in her head, hands, and legs, panic attacks, OCD intrusive thoughts, severe memory loss including inability to remember friends and eventually even close family, isolated incidents of rages, speech regression, and vision abnormalities (inability to see people in color). She also lost her ability to read for several months and was unable to write correctly or remember how to spell for several months. These did not happen all at once but have been issue we've dealt with since the initial onset. AE resulted: in Doctor or other healthcare professional Office clinic visit, Emergency Room department or urgent care, Hospitalization, Disability or permanent damage. No. days hospitalization: 4. AE treatment: ERP and CBT, OT. The patient did not received any other vaccines within 4 weeks prior to the covid 19 vaccine. The patient had not been diagnosed with COVID-19 prior to vaccination and had been tested post the vaccination with nasal swab test (test name: BinaxNow) on 27May2022 resulted in positive. The patient had no known allergies. Other medical history: None prior to these events.